Colección SciELO Chile

Departamento Gestión de Conocimiento, Monitoreo y Prospección
Consultas o comentarios: productividad@anid.cl
Búsqueda Publicación
Búsqueda por Tema Título, Abstract y Keywords



Free-breathing 3D whole-heart joint T1/T2 mapping and water/fat imaging at 0.55 T
Indexado
WoS WOS:001247169600001
Scopus SCOPUS_ID:85196109582
DOI 10.1002/MRM.30139
Año 2024
Tipo artículo de investigación

Citas Totales

Autores Afiliación Chile

Instituciones Chile

% Participación
Internacional

Autores
Afiliación Extranjera

Instituciones
Extranjeras


Abstract



Purpose: To develop and validate a highly efficient motion compensated free-breathing isotropic resolution 3D whole-heart joint T-1/T-2 mapping sequence with anatomical water/fat imaging at 0.55 T. Methods: The proposed sequence takes advantage of shorter T-1 at 0.55 T to acquire three interleaved water/fat volumes with inversion-recovery preparation, no preparation, and T-2 preparation, respectively. Image navigators were used to facilitate nonrigid motion-compensated image reconstruction. T-1 and T-2 maps were jointly calculated by a dictionary matching method. Validations were performed with simulation, phantom, and in vivo experiments on 10 healthy volunteers and 1 patient. The performance of the proposed sequence was compared with conventional 2D mapping sequences including modified Look-Locker inversion recovery and T-2-prepared balanced steady-SSFP sequence. Results: The proposed sequence has a good T-1 and T-2 encoding sensitivity in simulation, and excellent agreement with spin-echo reference T-1 and T-2 values was observed in a standardized T-1/T-2 phantom (R-2 = 0.99). In vivo experiments provided good-quality co-registered 3D whole-heart T-1 and T-2 maps with 2-mm isotropic resolution in a short scan time of about 7 min. For healthy volunteers, left-ventricle T-1 mean and SD measured by the proposed sequence were both comparable with those of modified Look-Locker inversion recovery (640 +/- 35 vs. 630 +/- 25 ms [p = 0.44] and 49.9 +/- 9.3 vs. 54.4 +/- 20.5 ms [p = 0.42]), whereas left-ventricle T-2 mean and SD measured by the proposed sequence were both slightly lower than those of T-2-prepared balanced SSFP (53.8 +/- 5.5 vs. 58.6 +/- 3.3 ms [p < 0.01] and 5.2 +/- 0.9 vs. 6.1 +/- 0.8 ms [p = 0.03]). Myocardial T-1 and T-2 in the patient measured by the proposed sequence were in good agreement with conventional 2D sequences and late gadolinium enhancement. Conclusion: The proposed sequence simultaneously acquires 3D whole-heart T-1 and T-2 mapping with anatomical water/fat imaging at 0.55 T in a fast and efficient 7-min scan. Further investigation in patients with cardiovascular disease is now warranted.

Métricas Externas



PlumX Altmetric Dimensions

Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:

Disciplinas de Investigación



WOS
Radiology, Nuclear Medicine & Medical Imaging
Scopus
Sin Disciplinas
SciELO
Sin Disciplinas

Muestra la distribución de disciplinas para esta publicación.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Colaboración Institucional



Muestra la distribución de colaboración, tanto nacional como extranjera, generada en esta publicación.


Autores - Afiliación



Ord. Autor Género Institución - País
1 Si, Dongyue - Kings Coll London - Reino Unido
King's College London - Reino Unido
2 Crabb, Michael G. - Kings Coll London - Reino Unido
King's College London - Reino Unido
3 Kunze, Karl P. Hombre Kings Coll London - Reino Unido
Siemens Healthcare Ltd - Reino Unido
King's College London - Reino Unido
Siemens Healthcare Limited - Reino Unido
4 Littlewood, Simon J. - Kings Coll London - Reino Unido
King's College London - Reino Unido
5 PRIETO-VASQUEZ, CLAUDIA DEL CARMEN Mujer Kings Coll London - Reino Unido
Pontificia Universidad Católica de Chile - Chile
Millennium Inst Intelligent Healthcare Engn - Chile
Instituto Milenio en Ingeniería e Inteligencia Artificial para la Salud - Chile
King's College London - Reino Unido
6 Botnar, Reneprime M. Hombre Kings Coll London - Reino Unido
Pontificia Universidad Católica de Chile - Chile
Millennium Inst Intelligent Healthcare Engn - Chile
TECH UNIV MUNICH - Alemania
Instituto Milenio en Ingeniería e Inteligencia Artificial para la Salud - Chile
British Heart Foundation - Reino Unido
Technische Universität München - Alemania
King's College London - Reino Unido

Muestra la afiliación y género (detectado) para los co-autores de la publicación.

Financiamiento



Fuente
British Heart Foundation
Department of Health
Engineering and Physical Sciences Research Council
Wellcome EPSRC Centre for Medical Engineering
Technische Universität München
National Institute for Health and Care Research
Institute for Advanced Studies, University of Bristol
National Institute for Health and Research Cardiovascular MedTech Co-operative
ANID IMPACT
ANID Millennium Institute for Intelligent Healthcare Engineering
BHF Center for Award Excellence
National Institute for Health and Research Cardiovascular MedTech Co‐operative
Basal Center of Interventional Medicine for Precision and Advanced Cellular Therapy

Muestra la fuente de financiamiento declarada en la publicación.

Agradecimientos



Agradecimiento
Wellcome EPSRC Centre for Medical Engineering, Grant/Award Number: NS/A000049/1; the Department of Health through the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award; ANID Millenium Institute for Intelligent Healthcare Engineering, Grant/Award Number: ICN2021_004; EPSRC, Grant/Award Number: EP/V044087/1; ANID IMPACT, Basal Center of Interventional Medicine for Precision and Advanced Cellular Therapy, Grant/Award Number: FB210024; British Heart Foundation, Grant/Award Number: RG/20/1/34802; the Technical University of Munich - Institute for Advanced Study; National Institute for Health and Research Cardiovascular MedTech Co-operativeThe authors acknowledge financial support from British Heart Foundation programme grant (RG/20/1/34802) and King's BHF Center for Award Excellence (RE/18/2/34213); EPSRC (EP/V044087/1); Wellcome EPSRC Center for Medical Engineering (NS/A000049/1); ANID Millennium Institute for Intelligent Healthcare Engineering (ICN2021_004); ANID IMPACT, Basal Center of Interventional Medicine for Precision and Advanced Cellular Therapy (FB210024); the Department of Health through the National Institute for Health Research (NIHR) comprehensive Biomedical Research Center award; National Institute for Health and Research Cardiovascular MedTech Co-operative; and the Technical University of Munich-Institute for Advanced Study. The views expressed are those of the authors and not necessarily those of the BHF, NHS, the NIHR, or the Department of Health.r No Statement Availabler No Statement Availabler No Statement Availabler No Statement Availabler No Statement Availabler No Statement Availabler No Statement Available
The authors acknowledge financial support from British Heart Foundation programme grant (RG/20/1/34802) and King's BHF Center for Award Excellence (RE/18/2/34213); EPSRC (EP/V044087/1); Wellcome EPSRC Center for Medical Engineering (NS/A000049/1); ANID Millennium Institute for Intelligent Healthcare Engineering (ICN2021_004); ANID IMPACT, Basal Center of Interventional Medicine for Precision and Advanced Cellular Therapy (FB210024); the Department of Health through the National Institute for Health Research (NIHR) comprehensive Biomedical Research Center award; National Institute for Health and Research Cardiovascular MedTech Co\u2010operative; and the Technical University of Munich\u2013Institute for Advanced Study. The views expressed are those of the authors and not necessarily those of the BHF, NHS, the NIHR, or the Department of Health.

Muestra la fuente de financiamiento declarada en la publicación.